Skip to main content
Equibles
VRDN logo

VRDN · Viridian Therapeutics, Inc.\DE · Webcasts, Transcripts & Audio

Track VRDN — free

Use VRDN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VRDN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.35 +0.13 (+0.71%)
Russell 2000 member Rebalance outlook locked
Market Cap
$2.32B
Shares
113.29M
Volume · Oct 7 346.86K Avg daily vol (3M) 1.73M

Viridian Therapeutics, Inc.\DE Webcasts

Earnings calls, investor updates, investor days and conferences for Viridian Therapeutics, Inc.\DE (VRDN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲84.9% $880,000 −$10.12M '19 Q4 20-03-11 ▲122.6% $828,000 −$8.04M '20 Q1 20-05-07 ▼93.3% $168,000 −$6.43M '20 Q2 20-08-05 ▼93.9% $54,000 −$90.74M '20 Q4 21-03-25 ▲296.3% $214,000 −$28.95M '21 Q4 22-03-10 ▼85.1% $216,000 −$25.69M '22 Q1 22-05-12 ▼76.5% $256,000 −$29.49M '22 Q2 22-08-15 ▼50.9% $105,000 −$45.78M '22 Q4 23-03-08 ▼54.6% $98,000 −$68.15M '23 Q1 23-05-09 ▼94% $72,000 −$47.66M '23 Q3 23-11-13 ▼26.5% $72,000 −$48.54M '24 Q1 24-05-08 ▲0% $72,000 −$79.72M '24 Q4 25-02-27 ▲0% $72,000 −$86.91M '25 Q1 25-05-06 ▲81958.1% $70.57M −$34.60M '25 Q3 25-11-05 ▲83.3% $132,000 −$120.36M '25 Q4 26-02-26 LATEST ▲95.8% $141,000 −$104.90M '26 Q1 26-05-05
Conference
Investor event
2026-09-08
Viridian Therapeutics, Inc.\DE (VRDN) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-09
Viridian Therapeutics, Inc.\DE (VRDN) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Viridian Therapeutics, Inc.\DE (VRDN) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Viridian Therapeutics, Inc.\DE (VRDN) Q1 2026 Earnings Call
Revenue
$141,000
▲ 95.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Viridian Therapeutics, Inc.\DE (VRDN) Q4 2025 Earnings Call
Revenue
$132,000*
▲ 83.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Viridian Therapeutics, Inc.\DE (VRDN) Q3 2025 Earnings Call
Revenue
$70.57M
▲ 81958.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Viridian Therapeutics, Inc.\DE (VRDN) Q1 2025 Earnings Call
Revenue
$72,000
▲ 0% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Viridian Therapeutics, Inc.\DE (VRDN) Q4 2024 Earnings Call
Revenue
$72,000*
▲ 0% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q1
2024-05-08
Viridian Therapeutics, Inc.\DE (VRDN) Q1 2024 Earnings Call Transcript
Confident tone TED market opportunity FcRn portfolio (006, 008) 001 IV program / BLA timeline
Revenue
$72,000
▼ 26.5% YoY
Diluted EPS
$-0.79
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q3
2023-11-13
Viridian Therapeutics, Inc.\DE (VRDN) Q3 2023 Earnings Call
Revenue
$72,000
▼ 94% YoY
Diluted EPS
$-1.09
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Viridian Therapeutics, Inc.\DE (VRDN) Q1 2023 Earnings Call Transcript
Revenue
$98,000
▼ 54.6% YoY
Diluted EPS
$-1.61
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-08
Viridian Therapeutics, Inc.\DE (VRDN) Q4 2022 Earnings Call Transcript
Revenue
$105,000*
▼ 50.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-08-15
Viridian Therapeutics, Inc.\DE (VRDN) Q2 2022 Earnings Call Transcript
Revenue
$256,000
▼ 76.5% YoY
Diluted EPS
$-1.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Viridian Therapeutics, Inc.\DE (VRDN) Q1 2022 Earnings Call Transcript
Revenue
$216,000
▼ 85.1% YoY
Diluted EPS
$-0.98
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
Viridian Therapeutics, Inc.\DE (VRDN) Q4 2021 Earnings Call Transcript
Revenue
$214,000*
▲ 296.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q4
2021-03-25
Viridian Therapeutics, Inc.\DE (VRDN) Q4 2020 Earnings Call Transcript
Revenue
$54,000*
▼ 93.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2020-08-05
Viridian Therapeutics, Inc.\DE (VRDN) Q2 2020 Earnings Call Transcript
Revenue
$168,000
▼ 93.3% YoY
Diluted EPS
$-1.82
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Viridian Therapeutics, Inc.\DE (VRDN) Q1 2020 Earnings Call Transcript
Revenue
$828,000
▲ 122.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-11
Viridian Therapeutics, Inc.\DE (VRDN) Q4 2019 Earnings Call
Revenue
$880,000
▲ 84.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–19 of 19 webcasts
Key facts CIK 1590750 CUSIP 92790C104 13F (30d) 4 filings 4 filers Visit website Investor relations